Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine for aromatase inhibitor-associated musculoskeletal symptoms
NCT01598298Phase 3Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- May 2013
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of duloxetine in Aromatase Inhibitor-Associated Musculoskeletal Symptoms (AIMSS), sponsored by SWOG Cancer Research Network. Started May 2013; status: completed.
02
Drugs
duloxetine
03
Conditions
Aromatase Inhibitor-Associated Musculoskeletal Symptoms (AIMSS)
Beyond the preview
Go deeper on NCT01598298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01598298.